Related Experiment Videos

Screening laboratory tests for Crohn's disease

Insights

Fecal alpha 1-antitrypsin (FA) concentration is the most sensitive screening test for pediatric Crohn's disease. Children without abnormal FA values, anemia, elevated ESR, or hypoalbuminemia are unlikely to have active disease.

Area of Science:

  • Pediatric Gastroenterology
  • Inflammatory Bowel Disease Research
  • Clinical Diagnostics

Background:

  • Crohn's disease (CD) is a chronic inflammatory bowel disease.
  • Accurate and early diagnosis in pediatric patients is crucial.
  • Screening laboratory tests can aid in identifying potential CD cases.

Purpose of the Study:

  • To evaluate the prevalence of abnormal screening laboratory test values in children diagnosed with Crohn's disease.
  • To identify the most sensitive screening tests for pediatric CD.

Main Methods:

  • Retrospective analysis of 24 pediatric patients with confirmed Crohn's disease.
  • Assessment of initial screening laboratory tests: fecal alpha 1-antitrypsin (FA) concentration, erythrocyte sedimentation rate (ESR), leukocyte count, serum albumin, hemoglobin, and stool occult blood.
  • Correlation of abnormal test results with the diagnosis of Crohn's disease.

Main Results:

  • All 24 patients (100%) exhibited at least one abnormal screening test value.
  • Fecal alpha 1-antitrypsin (FA) concentration was abnormal in 21 patients (87.5%).
  • Other frequent abnormalities included anemia (70.8%), elevated ESR (79.2%), and hypoalbuminemia (58.3%). Leukocytosis was not observed.

Conclusions:

  • Fecal alpha 1-antitrypsin (FA) concentration is a highly sensitive screening marker for pediatric Crohn's disease.
  • The combination of screening tests effectively identifies potential CD cases.
  • Pediatric patients lacking abnormalities in FA, anemia, ESR, and albumin are unlikely to have active Crohn's disease, aiding in differential diagnosis.

Related Concept Videos